+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID07390422

Evaluating Pulsed Electric Field Therapy of the Duodenum for Adults with Type 2 Diabetes and Fatty Liver Disease DRESS-1 Study

Led by Chinese University of Hong Kong · Updated on 2026-09-15

40

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, effectiveness, and biological effects of the pulsENDO procedure in adults with type 2 diabetes mellitus T2DM who have not achieved sufficient blood sugar control with oral medications. The study also examines how this procedure impacts metabolically associated fatty liver disease MASLD. This single-arm feasibility study enrolls participants with T2DM of less than 10 years duration and tracks outcomes over two years. Participants will receive the pulsENDO procedure, which involves using a catheter inserted through the mouth to deliver pulsed electric fields to the duodenum, targeting approximately 10 to 18 cm of duodenal tissue to promote cell regeneration. Liver biopsies are taken before and after the procedure to assess effects on fatty liver disease. If needed, participants may have a repeat pulsENDO procedure between 1 and 2 years after the initial treatment if diabetes control worsens. Follow-up extends for 12 months after the first procedure and an additional year after any repeat treatment. Throughout the study, participants undergo evaluations including liver biopsies, blood tests to measure HbA1c and other metabolic markers, body composition assessments, and quality of life questionnaires. Researchers monitor changes in body weight, body fat percentage, medication use, and the gut microbiome. Safety is tracked by recording any adverse events within 30 days post-procedure. The total study participation can last up to three years, including follow-up after potential repeat treatments.

CONDITIONS

Brief Title

Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease

Research Team

S

Stephen Ng, FRCSEd(Gen)

J

Jenny Study coordinator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here